5,6-Methylenedioxy-2-aminoindane : from laboratory curiosity to 'legal high'

Gallagher, C. T., Assi, S., Stair, J. L., Fergus, S., Corazza, Ornella, Corkery, John and Schifano, Fabrizio (2012) 5,6-Methylenedioxy-2-aminoindane : from laboratory curiosity to 'legal high'. Human Psychopharmacology: Clinical and Experimental (2). pp. 106-112. ISSN 1099-1077
Copy

The fully synthetic 'legal high' 5,6-methylenedioxy-2-aminoindane (MDAI) is an analogue of 3,4-methylenedioxymethamphetamine. Although developed in the 1990s, it was not widely abused until 2010. However, mephedrone was banned in the UK in April 2010, and almost immediately, MDAI was widely advertised as a legal alternative. This paper provides both an overview of the current state of knowledge of MDAI and a critical analysis of online available information relating to its psychoactive effects, adverse reactions and use in combination with other drugs.

Full text not available from this repository.

EndNote BibTeX Reference Manager Refer Atom Dublin Core Data Cite XML RIOXX2 XML OpenURL ContextObject in Span METS HTML Citation MPEG-21 DIDL ASCII Citation OpenURL ContextObject MODS
Export

Downloads